Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer
Top Cited Papers
- 1 September 2001
- journal article
- review article
- Published by Elsevier BV in The Lancet Oncology
- Vol. 2 (9), 544-551
- https://doi.org/10.1016/s1470-2045(01)00488-0
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid ArthritisJAMA, 2000
- INHIBITION OF CYCLOOXYGENASE-2 SUPPRESSES ANGIOGENESIS AND THE GROWTH OF PROSTATE CANCER IN VIVOJournal of Urology, 2000
- The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous PolyposisNew England Journal of Medicine, 2000
- Xenobiotic-metabolizing Cytochromes P450 Convert Prostaglandin Endoperoxide to Hydroxyheptadecatrienoic Acid and the Mutagen, MalondialdehydeJournal of Biological Chemistry, 2000
- A Selective Cyclooxygenase-2 Inhibitor Suppresses Tumor Growth in Nude Mouse Xenografted with Human Head and Neck Squamous Carcinoma CellsJapanese Journal of Cancer Research, 1999
- Effect of α-Difluoromethylornithine on Rectal Mucosal Levels of Polyamines in a Randomized, Double-Blinded Trial for Colon Cancer PreventionJNCI Journal of the National Cancer Institute, 1998
- Inhibition of lung tumourigenesis by sulindac: comparison of two experimental protocolsCarcinogenesis: Integrative Cancer Research, 1997
- Prostaglandin synthase 2Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1996
- Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin‐1: a potential mechanism for inflammatory angiogenesisFEBS Letters, 1995
- Chemoprevention of OH-BBN-induced bladder cancer in mice by piroxicamCarcinogenesis: Integrative Cancer Research, 1993